Entity Common Stock, Shares Outstanding of Vivani Medical, Inc. from 11 May 2015 to 12 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Vivani Medical, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 11 May 2015 to 12 Nov 2025.
  • Vivani Medical, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 12 Nov 2025 was 72,952,235, a 23% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Vivani Medical, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 72,952,235 +13,717,546 +23% 12 Nov 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 59,243,903 +3,988,047 +7.2% 12 Aug 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 59,242,903 +4,264,903 +7.8% 28 Mar 2025 10-K 31 Mar 2025 2024 FY
Q3 2024 59,234,689 +8,209,629 +16% 12 Nov 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 55,255,856 +4,437,057 +8.7% 12 Aug 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 54,978,000 +4,242,230 +8.4% 22 Mar 2024 10-K 26 Mar 2024 2023 FY
Q3 2023 51,025,060 +289,290 +0.57% 10 Nov 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 50,818,799 +11,409,623 +29% 10 Aug 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 50,735,770 +11,326,594 +29% 27 Mar 2023 10-K 31 Mar 2023 2022 FY
Q3 2022 50,735,770 +11,326,594 +29% 11 Nov 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 39,409,176 0 0% 08 Aug 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 39,409,176 +16,158,869 +70% 23 Mar 2022 10-K 29 Mar 2022 2021 FY
Q3 2021 39,409,176 +16,290,943 +70% 10 Nov 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 39,409,176 +16,290,943 +70% 11 Aug 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 23,250,307 +7,592,607 +48% 13 Mar 2021 10-K 16 Mar 2021 2020 FY
Q3 2020 23,118,233 -101,479,965 -81% 10 Nov 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 23,118,233 -101,468,090 -81% 25 Jun 2020 10-Q 26 Jun 2020 2020 Q1
Q1 2020 15,657,700 -108,540,261 -87% 13 Mar 2020 10-K 19 Mar 2020 2019 FY
Q3 2019 124,598,198 +51,817,649 +71% 12 Nov 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 124,586,323 +57,511,781 +86% 06 Aug 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 124,197,961 +64,339,119 +107% 12 Mar 2019 10-K 19 Mar 2019 2018 FY
Q3 2018 72,780,549 +15,974,197 +28% 02 Nov 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 67,074,542 +10,280,065 +18% 03 Aug 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 59,858,842 +3,493,213 +6.2% 13 Mar 2018 10-K 20 Mar 2018 2017 FY
Q3 2017 56,806,352 +14,559,398 +34% 03 Nov 2017 10-Q 06 Nov 2017 2017 Q3
Q2 2017 56,794,477 +14,595,023 +35% 04 Aug 2017 10-Q 07 Aug 2017 2017 Q2
Q1 2017 56,365,629 +20,346,543 +56% 14 Mar 2017 10-K 16 Mar 2017 2016 FY
Q3 2016 42,246,954 +6,395,554 +18% 02 Nov 2016 10-Q 04 Nov 2016 2016 Q3
Q2 2016 42,199,454 +6,373,435 +18% 05 Aug 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 36,019,086 +621,938 +1.8% 08 Mar 2016 10-K 11 Mar 2016 2015 FY
Q3 2015 35,851,400 06 Nov 2015 10-Q 16 Nov 2015 2015 Q3
Q2 2015 35,826,019 31 Jul 2015 10-Q 05 Aug 2015 2015 Q2
Q1 2015 35,397,148 11 May 2015 10-Q 15 May 2015 2015 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.